国际儿童创伤性脑损伤人群中的持续脑电图与抗癫痫药物使用
21.9%在PICU期间接受cEEG监测。cEEG监测组治疗剂量抗癫痫药物使用率显著高于未监测组(66.7% vs 28.1%,p=0.0002)。治疗ASM组首次EEG电graphic发作(51.6% vs 4%)和临床发作(55.8% vs 0%)均更多。cEEG监测组基线GCS更差(中位7 vs 9),既往癫痫和神经肌肉阻滞使用更常见。
要点
- 儿童TBI后cEEG监测与治疗剂量ASM使用增加相关(66.7% vs 28.1%,p=0.0002),可能反映电graphic发作识别增加。
- 接受治疗剂量ASM的患儿首次EEG电graphic发作率更高(51.6% vs 4%,p=0.0001),临床发作也更多(55.8% vs 0%,p<0.0001)。
- cEEG监测组基线GCS更差(中位7 vs 9,p=0.044),既往癫痫(18.2% vs 2.3%)和神经肌肉阻滞(52.4% vs 24.1%)更常见。
- 仅21.9%的儿童TBI患者接受cEEG监测,尽管电graphic发作常见且与不良预后相关。
- cEEG监测组与非监测组在年龄、颅内压监测使用或高渗治疗方面无显著差异。
适用人群与场景
- 7天至17岁急性神经损伤入住PICU的儿童TBI患者(PANGEA研究TBI队列)。
- 排除标准原文未提及。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- cEEG监测组治疗剂量ASM使用率66.7%,未监测组28.1%(p=0.0002)。
- 治疗ASM组首次EEG电graphic发作51.6%,无治疗ASM组4%(p=0.0001);临床发作分别为55.8%和0%(p<0.0001)。
- cEEG监测组既往癫痫18.2% vs 2.3%(p=0.014),神经肌肉阻滞52.4% vs 24.1%(p=0.011),基线GCS中位7 vs 9(p=0.044)。
- 年龄、颅内压监测使用、高渗治疗在两组间无显著差异。
证据类型、等级与局限
- 证据类型:国际多中心队列研究的亚组分析(观察性研究);证据等级或推荐强度原文未提及。
对床旁实践的改变
- 在儿童TBI患者中,cEEG监测可能有助于识别电graphic发作,从而增加治疗剂量ASM的使用;但本研究为观察性分析,不能证明cEEG监测改善预后。
- 对于GCS较差、既往有癫痫或使用神经肌肉阻滞的儿童TBI患者,cEEG监测使用率更高,临床可考虑对这些高危人群加强EEG监测。
- 不适用人群:原文未提及。
- 常见陷阱:不能将cEEG监测与治疗ASM使用的相关性误解为cEEG监测或ASM治疗能改善结局;本研究未提供预后数据。
指南或共识出处
- 原文未提及指南或共识名称;研究来自PANGEA研究TBI队列。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Electrographic seizures are frequent and associated with worse outcomes following traumatic brain injury (TBI). Despite this, the use of continuous electroencephalogram (cEEG) remains low. Our study describes cEEG usage and treatment dosing antiseizure medications (ASMs) in an international pediatric TBI population, hypothesizing that children monitored with cEEG have an increased rate of treatment ASMs because of electrographic seizure detection, compared with children who are not monitored with cEEG.
METHODS: This subanalysis of the TBI cohort of the international PANGEA study included children, 7 days to 17 years of age, with acute neurological insults admitted to pediatric intensive care units. We analyzed demographics, injury severity, and therapies including prophylactic or treatment ASMs. We evaluated the relationships between cEEG use, seizure frequency, and receipt of treatment ASMs. [Formula: see text] or Fisher's exact test was used to analyze categorical variables, and the Kruskal-Wallis or Mann-Whitney U-test was used for continuous variables. Multivariable analysis for treatment ASM use was performed using logistic regression.
RESULTS: One hundred-twenty-three of 174 patients with TBI were included. Twenty-seven patients (21.9%) underwent cEEG at any point during pediatric intensive care unit admission. Preexisting seizure disorder (18.2% vs. 2.3%, p = 0.014) and neuromuscular blockade use (52.4% vs. 24.1%, p = 0.011) were more frequently observed in the group monitored on cEEG when compared with those that were not. Presenting median Glasgow Coma Scale score was worse in the cEEG group (7 vs. 9, p = 0.044). There was no significant difference in age, use of intracranial pressure monitoring, or hyperosmolar therapy between the cEEG monitored and nonmonitored groups. Patients who were monitored on cEEG were more likely to receive a treatment dose ASM than those without cEEG monitoring (66.7% vs. 28.1%, p = 0.0002). When compared with those without treatment ASM, the treatment ASM group had more electrographic seizures on their first electroencephalogram following injury (51.6% vs. 4%, p = 0.0001) and more clinical seizures (55.8% vs. 0%, p < 0.0001).
CONCLUSIONS: Children monitored with cEEG after TBI have an increased prescription of treatment ASMs and clinical and electrographic seizures. The increased rate of treatment ASMs in the cEEG group may indicate increased recognition of electrographic seizures.
参考来源
- Snooks KC, Yan K, Farias-Moeller R, et al. Continuous Electroencephalogram and Antiseizure Medication Use in an International Pediatric Traumatic Brain Injury Population. Neurocrit Care. 2021. PMID: 34553297. doi:10.1007/s12028-021-01337-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。